PMA device
Propel Contour Sinus Implant
Intersect Ent. · Drug-Eluting Sinus Stent (OWO, Class III) · First FDA decision Feb 23, 2017, newest Feb 23, 2017Chronic sinusitis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
4
Naming "Propel Contour"
MAUDE reports
4
Brand "Propel Contour", since 2015
PubMed studies
1
Mentioning "Propel Contour"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Propel Contour Sinus Implant
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- PROPEL CONTOUR SINUS IMPLANTPMA supplement
P100044-S023 · Decided Feb 23, 2017 · 206 days after receipt · Panel Track
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Propel Contour", any status and sponsor, newest update first.
MedtronicPublic (MDT)
NCT06671561 · 0 participants · Start Jan 30, 2025 · Primary completion Aug 2026
Device: Observational data collection from patients with chronic rhinosinusitis (CRS) receiving PROPEL sinus implant(s) following functional endoscopic sinus surgery (FESS) · For: Chronic Rhinosinusitis (CRS)
Intersect ENTNot on our public-company list
NCT04858802 · 80 participants · Start May 12, 2021 · Primary completion Feb 10, 2022
Device: PROPEL Contour Sinus Implant · For: Chronic Rhinosinusitis (Diagnosis)
Sites: Sacramento, California; San Francisco, California; Boca Raton, Florida · 14 sites in all
- Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal SinusPivotal-lookingCompleted
Intersect ENTNot on our public-company list
NCT02266810 · 160 participants · Start Sep 2014 · Primary completion Apr 2016
Device: PROPEL Mini Sinus Implant.; Propel Nova Sinus Implant · For: Chronic Sinusitis
Sites: Sacramento, California; Torrance, California; Norwalk, Connecticut · 10 sites in all
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Propel Contour", and for the whole product code for context.
This brand
4 reports: 1 malfunction, 3 injury, 0 death
Whole product code OWO
36 reports: 7 malfunction, 29 injury, 0 death
Newest reports for this brand
3008301917-2020-00001 · Received Oct 22, 2020 · Event dated Sep 22, 2020
Device type: Drug-Eluting Sinus Stent (OWO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Loss of consciousness; Syncope/Fainting
9896920 · Received Mar 30, 2020 · Event dated Mar 13, 2020
Device type: Drug-Eluting Sinus Stent (OWO)
Device problem as coded: Defective Device
Patient problem as coded: No Consequences Or Impact To Patient
3008301917-2018-00004 · Received Jul 17, 2018 · Event dated Apr 26, 2018
Device type: Drug-Eluting Sinus Stent (OWO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Cerebrospinal Fluid Leakage
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Propel Contour"[tiab]. The summary above synthesizes these.
- Revision Surgical Management of Refractory Nasal Vestibular Stenosis in an Exotic Shorthair Cat Using a Combined Surgical Technique and a Steroid-Eluting Implant (PROPEL Contour).
Kim HM, Son SJ, Jeon SH, et al. · Vet Sci · 2026Case Reports
Other devices of this type
Also filed under product code OWO.
- PropelIntersect Ent. · PMA 2020
- Propel Mini Sinus ImplantIntersect Ent. · PMA 2016
- Intersect Ent Propel Mini Sinus ImplantIntersect Ent. · PMA 2014
- Intersectent Propel Mini Sinus ImplantIntersect Ent. · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.